BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15628665)

  • 21. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist.
    Heusler P; Rauly-Lestienne I; Tourette A; Tardif S; Ailhaud MC; Croville G; Cussac D
    Eur J Pharmacol; 2010 Aug; 640(1-3):8-14. PubMed ID: 20450907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of agonist and antagonist interactions in serotonin 1A receptors by alcohols.
    Harikumar KG; Chattopadhyay A
    FEBS Lett; 1998 Oct; 438(1-2):96-100. PubMed ID: 9821966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of antagonist binding to serotonin1A receptors from bovine hippocampus by metal ions.
    Harikumar KG; Chattopadhyay A
    Cell Mol Neurobiol; 2001 Oct; 21(5):453-64. PubMed ID: 11860184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y; Toyoshima R
    Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Native rat hippocampal 5-HT1A receptors show constitutive activity.
    Martel JC; Ormière AM; Leduc N; Assié MB; Cussac D; Newman-Tancredi A
    Mol Pharmacol; 2007 Mar; 71(3):638-43. PubMed ID: 17167032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization.
    Zimmer L; Riad M; Rbah L; Belkacem-Kahlouli A; Le Bars D; Renaud B; Descarries L
    Neuroimage; 2004 Jul; 22(3):1421-6. PubMed ID: 15219613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635.
    Newman-Tancredi A; Conte C; Chaput C; Spedding M; Millan MJ
    Br J Pharmacol; 1997 Mar; 120(5):737-9. PubMed ID: 9138675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ca2+ responses in Chinese hamster ovary-K1 cells demonstrate an atypical pattern of ligand-induced 5-HT1A receptor activation.
    Pauwels PJ; Colpaert FC
    J Pharmacol Exp Ther; 2003 Nov; 307(2):608-14. PubMed ID: 12970382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
    J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of serotonin1A receptors from bovine hippocampus with tertiary amine local anesthetics.
    Kalipatnapu S; Chattopadhyay A
    Cell Mol Neurobiol; 2004 Jun; 24(3):403-22. PubMed ID: 15206822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons.
    Cowen DS; Johnson-Farley NN; Travkina T
    J Neurochem; 2005 May; 93(4):910-7. PubMed ID: 15857394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors.
    Arthur JM; Casañas SJ; Raymond JR
    Biochem Pharmacol; 1993 Jun; 45(11):2337-41. PubMed ID: 8517875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
    Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
    Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells.
    Newman-Tancredi A; Wootton R; Strange PG
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):933-8. PubMed ID: 1386736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.